Skip to main content
OpenTrials

Clinical trial condition

Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)

Explore clinical trials studying Long-chain Fatty Acid Oxidation Disorders (LC-FAOD). Study availability and eligibility vary by location and protocol.

4 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) trial results

Active, not recruiting

A Study to Determine the Effect of Triheptanoin Compared With Even-Chain MCT on MCEs in Pediatric Patients With LC-FAOD

NCT05933200

Conditions
Long-chain Fatty Acid Oxidation Disorders (LC-FAOD), VLCAD deficiency
Locations
  • General University Hospital in Prague-GUH (Všeobecná fakultní nemocnice v Praze- VFN) Prague, Czechia
  • Universitätsklinikum Freiburg Freiburg im Breisgau, Germany
  • Juntendo University Hospital Bunkyo City, Tokyo, Japan
  • The Jikei University Hospital Minato, Tokyo, Japan
View all 15 locations
View Trial Details
Active, not recruiting

Long-Chain Fatty Acid Oxidation Disorders In-Clinic Disease Monitoring Program

NCT04632953

Conditions
Carnitine-Acylcarnitine Translocase Deficiency, Long-chain Fatty Acid Oxidation Disorders (LC-FAOD), Trifunctional Protein Deficiency With Myopathy And Neuropathy, +1 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • University of California San Francisco San Francisco, California, United States
  • Children's Hospital of Colorado Aurora, Colorado, United States
  • University of South Florida Tampa, Florida, United States
View all 16 locations
View Trial Details
Completed

A Study of UX007 (Triheptanoin) in Participants With Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD)

NCT01886378

Conditions
Carnitine Palmitoyltransferase (CPT II) Deficiency, Long-chain Fatty Acid Oxidation Disorders (LC-FAOD), Longchain 3-hydroxy-acyl-CoA Dehydrogenase (LCHAD) Deficiency, +3 more
Locations
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • University of Southern Florida Tampa, Florida, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Clinical Outcome of Triheptanoin Treatment in Patients With Long-chain Fatty Acid Oxidation Disorders (LC-FAOD) Treated Under Expanded Access Program

NCT03768817

Conditions
Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • Kaiser Permanente Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Stanford University Palo Alto, California, United States
View all 15 locations
View Trial Details

Related conditions